{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:43:29Z","timestamp":1763545409610,"version":"3.45.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001432","UL1TR001409"],"award-info":[{"award-number":["KL2TR001432","UL1TR001409"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00812-x","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:30:10Z","timestamp":1763544610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers influence kidney function estimates more so than race among persons with HIV"],"prefix":"10.1186","volume":"22","author":[{"given":"Peggy-ita A.","family":"Obeng-Nyarkoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda B.","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Teran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Loffredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Luxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Timpone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Princy","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason G.","family":"Umans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seble G.","family":"Kassaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"812_CR1","unstructured":"CDC Surveillance System: CKD Stages Among U.S. Adults by Year. https:\/\/nccd.cdc.gov\/ckd\/detail.aspx?Qnum=Q372#refreshPosition. Accessed 20 Mar 2023."},{"key":"812_CR2","unstructured":"CDC Surveillance System: Trends in Prevalence of CKD Among U.S. Adults. https:\/\/nccd.cdc.gov\/ckd\/detail.aspx?Qnum=Q9&topic=1#refreshPosition. Accessed 11 June 2025."},{"issue":"1","key":"812_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12981-020-00266-3","volume":"17","author":"JE Heron","year":"2020","unstructured":"Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020;17(1):11. https:\/\/doi.org\/10.1186\/s12981-020-00266-3.","journal-title":"AIDS Res Ther"},{"issue":"9","key":"812_CR4","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1093\/cid\/ciu617","volume":"59","author":"GM Lucas","year":"2014","unstructured":"Lucas GM, Ross MJ, Stock PG, et al. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;59(9):e96\u2013138. https:\/\/doi.org\/10.1093\/cid\/ciu617.","journal-title":"Clin Infect Dis"},{"key":"812_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2019-11-1","volume":"9","author":"N Wearne","year":"2020","unstructured":"Wearne N, Davidson B, Blockman M, Swart A, Jones ES. HIV, drugs and the kidney. Drugs Context. 2020;9:1\u201317. https:\/\/doi.org\/10.7573\/dic.2019-11-1.","journal-title":"Drugs Context"},{"issue":"6","key":"812_CR6","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089\u2013100. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00365.x.","journal-title":"Kidney Int"},{"key":"812_CR7","unstructured":"GFR. National Kidney Foundation. 2014. https:\/\/www.kidney.org\/kidneydisease\/siemens_hcp_gfr. Accessed 7 Jan 2023."},{"key":"812_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21037\/jlpm.2018.09.07","volume":"3","author":"F Carrara","year":"2018","unstructured":"Carrara F, Gaspari F. GFR measured by iohexol: the best choice from a laboratory perspective. J Lab Precis Med. 2018;3:77\u201377. https:\/\/doi.org\/10.21037\/jlpm.2018.09.07.","journal-title":"J Lab Precis Med"},{"issue":"1","key":"812_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.ackd.2017.09.003","volume":"25","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Karger AB, Maahs DM. Measured GFR in routine clinical Practice\u2014The promise of dried blood spots. Adv Chronic Kidney Dis. 2018;25(1):76\u201383. https:\/\/doi.org\/10.1053\/j.ackd.2017.09.003.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"19","key":"812_CR10","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C\u2013Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"issue":"12","key":"812_CR11","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1681\/ASN.2021070988","volume":"32","author":"C Delgado","year":"2021","unstructured":"Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol. 2021;32(12):2994\u20133015. https:\/\/doi.org\/10.1681\/ASN.2021070988.","journal-title":"J Am Soc Nephrol"},{"key":"812_CR12","unstructured":"NKF KDOQI Guidelines. Accessed 7 Jan 2023. http:\/\/kidneyfoundation.cachefly.net\/professionals\/KDOQI\/guidelines_ckd\/p4_class_g1.htm"},{"issue":"1","key":"812_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","volume":"39","author":"AS Levey","year":"1988","unstructured":"Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39(1):465\u201390. https:\/\/doi.org\/10.1146\/annurev.me.39.020188.002341.","journal-title":"Annu Rev Med"},{"issue":"6","key":"812_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1053\/j.ajkd.2020.09.017","volume":"77","author":"PS Garimella","year":"2021","unstructured":"Garimella PS, Tighiouart H, Sarnak MJ, Levey AS, Ix JH. Tubular secretion of creatinine and risk of kidney failure: the modification of diet in renal disease (MDRD) study. Am J Kidney Dis Off J Natl Kidney Found. 2021;77(6):992\u20134. https:\/\/doi.org\/10.1053\/j.ajkd.2020.09.017.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"3","key":"812_CR15","doi-asserted-by":"publisher","first-page":"100600","DOI":"10.1016\/j.xkme.2023.100600","volume":"5","author":"ER Gottlieb","year":"2023","unstructured":"Gottlieb ER, Estiverne C, Tolan NV, Melanson SEF, Mendu ML. Estimated GFR with Cystatin C and creatinine in clinical practice: A retrospective cohort study. Kidney Med. 2023;5(3):100600. https:\/\/doi.org\/10.1016\/j.xkme.2023.100600.","journal-title":"Kidney Med"},{"issue":"6","key":"812_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum Cystatin C levels. Kidney Int. 2009;75(6):652\u201360. https:\/\/doi.org\/10.1038\/ki.2008.638.","journal-title":"Kidney Int"},{"issue":"10","key":"812_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/hiv.12268","volume":"16","author":"S Gupta","year":"2015","unstructured":"Gupta S, Kitch D, Tierney C, et al. Markers of renal disease and function are associated with systemic inflammation in HIV infection: renal and inflammatory markers in HIV infection. HIV Med. 2015;16(10):591\u20138. https:\/\/doi.org\/10.1111\/hiv.12268.","journal-title":"HIV Med"},{"issue":"2","key":"812_CR18","first-page":"47","volume":"29","author":"JSC Chew","year":"2008","unstructured":"Chew JSC, Saleem M, Florkowski CM, George PM. Cystatin C\u2013a paradigm of evidence based laboratory medicine. Clin Biochem Rev. 2008;29(2):47\u201362.","journal-title":"Clin Biochem Rev"},{"key":"812_CR19","doi-asserted-by":"publisher","unstructured":"Onopiuk A, Tokarzewicz A, Gorodkiewicz E. Cystatin C. Advances in clinical chemistry. Vol. 68. Elsevier; 2015. pp. 57\u201369. https:\/\/doi.org\/10.1016\/bs.acc.2014.11.007","DOI":"10.1016\/bs.acc.2014.11.007"},{"issue":"4","key":"812_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ki.2010.431","volume":"79","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Schmid CH, et al. Changes in dietary protein intake has no effect on serum Cystatin C levels independent of the glomerular filtration rate. Kidney Int. 2011;79(4):471\u20137. https:\/\/doi.org\/10.1038\/ki.2010.431.","journal-title":"Kidney Int"},{"issue":"19","key":"812_CR21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/NEJMoa2103753","volume":"385","author":"Cyuan Hsu","year":"2021","unstructured":"Hsu Cyuan, Yang W, Parikh RV, et al. Race, genetic Ancestry, and estimating kidney function in CKD. N Engl J Med. 2021;385(19):1750\u201360. https:\/\/doi.org\/10.1056\/NEJMoa2103753.","journal-title":"N Engl J Med"},{"issue":"4","key":"812_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa2203769","volume":"388","author":"H Pottel","year":"2023","unstructured":"Pottel H, Bj\u00f6rk J, Rule AD, et al. Cystatin C\u2013Based equation to estimate GFR without the inclusion of race and sex. N Engl J Med. 2023;388(4):333\u201343. https:\/\/doi.org\/10.1056\/NEJMoa2203769.","journal-title":"N Engl J Med"},{"issue":"4","key":"812_CR23","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"1","key":"812_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ki.1995.40","volume":"47","author":"DJ Newman","year":"1995","unstructured":"Newman DJ, Thakkar H, Edwards RG, et al. Serum Cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47(1):312\u20138. https:\/\/doi.org\/10.1038\/ki.1995.40.","journal-title":"Kidney Int"},{"key":"812_CR25","unstructured":"Estimating Glomerular Filtration Rate | NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https:\/\/www.niddk.nih.gov\/health-information\/professionals\/clinical-tools-patient-management\/kidney-disease\/laboratory-evaluation\/glomerular-filtration-rate\/estimating. Accessed 7 Jan 2023."},{"key":"812_CR26","doi-asserted-by":"publisher","first-page":"gfw064","DOI":"10.1093\/ndt\/gfw064","volume":"15","author":"J Milburn","year":"2016","unstructured":"Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant Published Online April. 2016;15:gfw064. https:\/\/doi.org\/10.1093\/ndt\/gfw064.","journal-title":"Nephrol Dial Transplant Published Online April"},{"issue":"3","key":"812_CR27","first-page":"144","volume":"16","author":"P Maggi","year":"2014","unstructured":"Maggi P, Montinaro V, Mussini C, et al. Novel antiretroviral drugs and renal function monitoring of HIV patients. AIDS Rev. 2014;16(3):144\u201351.","journal-title":"AIDS Rev"},{"issue":"7","key":"812_CR28","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/jac\/dky112","volume":"73","author":"R Palich","year":"2018","unstructured":"Palich R, Tubiana R, Abdi B, et al. Plasma Cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART. J Antimicrob Chemother. 2018;73(7):1935\u20139. https:\/\/doi.org\/10.1093\/jac\/dky112.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"812_CR29","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1089\/AID.2017.0074","volume":"33","author":"Y Yoshino","year":"2017","unstructured":"Yoshino Y, Koga I, Seo K, Kitazawa T, Ota Y. Short communication: the clinical value of Cystatin C as a marker of renal function in HIV patients receiving dolutegravir. AIDS Res Hum Retroviruses. 2017;33(11):1080\u20132. https:\/\/doi.org\/10.1089\/AID.2017.0074.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"812_CR30","doi-asserted-by":"publisher","unstructured":"Cohen SD, Kopp JB, Kimmel PL. Kidney Diseases associated with human immunodeficiency virus infection. N Engl J Med. 2017;377(24):2363\u201374. https:\/\/doi.org\/10.1056\/NEJMra1508467","DOI":"10.1056\/NEJMra1508467"},{"issue":"2","key":"812_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/QAI.0000000000000557","volume":"69","author":"CT Longenecker","year":"2015","unstructured":"Longenecker CT, Kitch D, Sax PE, et al. Reductions in plasma Cystatin C after initiation of antiretroviral therapy are associated with reductions in inflammation: ACTG A5224s. J Acquir Immune Defic Syndr 1999. 2015;69(2):168\u201377. https:\/\/doi.org\/10.1097\/QAI.0000000000000557.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"5","key":"812_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/135965350601100502","volume":"11","author":"J Jaroszewicz","year":"2006","unstructured":"Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A. Does HAART improve renal function? An association between serum Cystatin C Concentration, HIV viral load and Haart duration. Antivir Ther. 2006;11(5):641\u20136. https:\/\/doi.org\/10.1177\/135965350601100502.","journal-title":"Antivir Ther"},{"issue":"8","key":"812_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/135965350801300810","volume":"13","author":"S Mauss","year":"2008","unstructured":"Mauss S, Berger F, Kuschak D, et al. Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients. Antivir Ther. 2008;13(8):1091\u20135.","journal-title":"Antivir Ther"},{"issue":"2","key":"812_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/aid.2011.0018","volume":"28","author":"ET Overton","year":"2012","unstructured":"Overton ET, Patel P, Mondy K, et al. Cystatin C and baseline renal function among HIV-Infected persons in the SUN study. AIDS Res Hum Retroviruses. 2012;28(2):148\u201355. https:\/\/doi.org\/10.1089\/aid.2011.0018.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"812_CR35","doi-asserted-by":"publisher","first-page":"1295217","DOI":"10.3389\/fmed.2024.1295217","volume":"11","author":"S Hanser","year":"2024","unstructured":"Hanser S, Choshi J, Mokoena H, et al. A systematic review assessing the potential use of Cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy. Front Med. 2024;11:1295217. https:\/\/doi.org\/10.3389\/fmed.2024.1295217.","journal-title":"Front Med"},{"issue":"20","key":"812_CR36","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-Kidney-Metabolic health: A presidential advisory from the American heart association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"issue":"2","key":"812_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1681\/ASN.2022070818","volume":"34","author":"JA Diao","year":"2023","unstructured":"Diao JA, Wu GJ, Wang JK, et al. National projections for clinical implications of Race-Free Creatinine-Based GFR estimating equations. J Am Soc Nephrol. 2023;34(2):309\u201321. https:\/\/doi.org\/10.1681\/ASN.2022070818.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"812_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and Cystatin C. N Engl J Med. 2012;367(1):20\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1114248.","journal-title":"N Engl J Med"},{"issue":"11","key":"812_CR39","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jama.2023.2154","volume":"329","author":"D Mohottige","year":"2023","unstructured":"Mohottige D, Purnell TS, Boulware LE. Redressing the harms of Race-Based kidney function Estimation. JAMA. 2023;329(11):881. https:\/\/doi.org\/10.1001\/jama.2023.2154.","journal-title":"JAMA"},{"issue":"2","key":"812_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jama.2019.5774","volume":"322","author":"ND Eneanya","year":"2019","unstructured":"Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 2019;322(2):113. https:\/\/doi.org\/10.1001\/jama.2019.5774.","journal-title":"JAMA"},{"issue":"3","key":"812_CR41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/ajt.16392","volume":"21","author":"PP Reese","year":"2021","unstructured":"Reese PP, Mohan S, King KL, et al. Racial disparities in preemptive waitlisting and deceased donor kidney transplantation: ethics and solutions. Am J Transpl. 2021;21(3):958\u201367. https:\/\/doi.org\/10.1111\/ajt.16392.","journal-title":"Am J Transpl"},{"issue":"2","key":"812_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41581-021-00501-8","volume":"18","author":"ND Eneanya","year":"2022","unstructured":"Eneanya ND, Boulware LE, Tsai J, et al. Health inequities and the inappropriate use of race in nephrology. Nat Rev Nephrol. 2022;18(2):84\u201394. https:\/\/doi.org\/10.1038\/s41581-021-00501-8.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"812_CR43","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/QAI.0b013e318222f461","volume":"57","author":"MM Estrella","year":"2011","unstructured":"Estrella MM, Parekh RS, Astor BC, et al. Chronic kidney disease and estimates of kidney function in HIV infection: A Cross-Sectional study in the multicenter AIDS cohort study. JAIDS J Acquir Immune Defic Syndr. 2011;57(5):380\u20136. https:\/\/doi.org\/10.1097\/QAI.0b013e318222f461.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"9","key":"812_CR44","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1681\/ASN.2021030311","volume":"32","author":"MG Atta","year":"2021","unstructured":"Atta MG, Zook K, Brown TT, et al. Racial adjustment adversely affects glomerular filtration estimates in black Americans living with HIV. J Am Soc Nephrol JASN. 2021;32(9):2143\u20137. https:\/\/doi.org\/10.1681\/ASN.2021030311.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"812_CR45","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/QAI.0000000000002471","volume":"85","author":"GM Lucas","year":"2020","unstructured":"Lucas GM, Atta MG, Zook K, et al. Cross-Sectional and longitudinal performance of Creatinine- and Cystatin C-Based estimating equations relative to exogenously measured glomerular filtration rate in HIV-Positive and HIV-Negative persons. JAIDS J Acquir Immune Defic Syndr. 2020;85(4):e58\u201366. https:\/\/doi.org\/10.1097\/QAI.0000000000002471.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"4","key":"812_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semnephrol.2016.05.003","volume":"36","author":"P Vart","year":"2016","unstructured":"Vart P, Grams ME. Measuring and assessing kidney function. Semin Nephrol. 2016;36(4):262\u201372. https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.003.","journal-title":"Semin Nephrol"},{"issue":"7","key":"812_CR47","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","volume":"26","author":"R Scherzer","year":"2012","unstructured":"Scherzer R, Estrella M, Li Y, et al. Association of Tenofovir exposure with kidney disease risk in HIV infection. AIDS Lond Engl. 2012;26(7):867\u201375. https:\/\/doi.org\/10.1097\/QAD.0b013e328351f68f.","journal-title":"AIDS Lond Engl"},{"issue":"1","key":"812_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12981-020-00268-1","volume":"17","author":"J Cohen","year":"2020","unstructured":"Cohen J, Beaubrun A, Bashyal R, Huang A, Li J, Baser O. Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries. AIDS Res Ther. 2020;17(1):12. https:\/\/doi.org\/10.1186\/s12981-020-00268-1.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"812_CR49","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1365-2125.2012.04440.x","volume":"75","author":"J Koteff","year":"2013","unstructured":"Koteff J, Borland J, Chen S, et al. A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of Iohexol and para-aminohippurate clearance in healthy subjects. Br J Clin Pharmacol. 2013;75(4):990\u20136. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04440.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"812_CR50","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/hiv.12784","volume":"20","author":"J Casado","year":"2019","unstructured":"Casado J, Monsalvo M, Vizcarra P, Fontecha M, Serrano-Villar S, Moreno S. Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine. HIV Med. 2019;20(10):648\u201356. https:\/\/doi.org\/10.1111\/hiv.12784.","journal-title":"HIV Med"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00812-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:30:11Z","timestamp":1763544611000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00812-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00812-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}